MLchartDataset catalogue

dual-target CAR-T cells BGT007

Term · Oncology and biomedicine · MLC-T-ONC-013181

A preparation of human T lymphocytes that have been genetically modified to express a chimeric antigen receptor (CAR) specific for two as of yet undisclosed tumor-associated antigens (TAAs), with potential immunostimulating and antineoplastic activities. Upon administration, the dual-target CAR-T cells BGT007 specifically recognize and induce selective toxicity in tumor cells expressing the two TAAs.

Table 1. Record
IdentifierMLC-T-ONC-013181
FieldOncology and biomedicine
Synonymsdual-target CAR T cells BGT007; bispecific CAR T cells BGT007
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-013181",
  "term": "dual-target CAR-T cells BGT007",
  "field": "Oncology and biomedicine",
  "definition": "A preparation of human T lymphocytes that have been genetically modified to express a chimeric antigen receptor (CAR) specific for two as of yet undisclosed tumor-associated antigens (TAAs), with potential immunostimulating and antineoplastic activities. Upon administration, the dual-target CAR-T cells BGT007 specifically recognize and induce selective toxicity in tumor cells expressing the two TAAs.",
  "synonyms": [
    "dual-target CAR T cells BGT007",
    "bispecific CAR T cells BGT007"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/dual-target-car-t-cells-bgt007/"
}

Record 6,276 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.